FDA issued a Warning Letter to Andapharm, LLC on 2/28/2019 as a result of this inspection.
FDA investigators audited the Andapharm - Fort Lauderdale, FL, United States facility and issued inspectional observations (via FDA 483) on 18 Jul 2018.
Add To Cart
- Category: Human Drugs
- Inspection end: 18 Jul 2018
- Location: Fort Lauderdale, United States
- FEI: 3005000348